Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Leukemia|October 3, 2003
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phaseS Branford, Z Rudzki, A Harper, et al.
Leukemia|March 14, 2009
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemiaA Hochhaus, S G O'Brien, F Guilhot, et al.
Leukemia|May 17, 2003
Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCRC H Hui, K Y Goh, D White, et al.
Leukemia|September 3, 2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRD M Ross, S Branford, J F Seymour, et al.
Scientific Reports|May 28, 2017
A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasmD A Casolari, T Nguyen, C M Butcher, et al.
Leukemia|May 4, 2007
Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurementsJ Saldanha, M Silvy, N Beaufils, et al.
Leukemia|March 27, 2012
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)B Hanfstein, M C Müller, R Hehlmann, et al.
Leukemia|April 26, 2016
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International ScaleN C P Cross, H E White, T Ernst, et al.
Pageof 2